<DOC>
	<DOCNO>NCT01137019</DOCNO>
	<brief_summary>The purpose study use high-resolution intracoronary imaging modality , call optical coherence tomography ( OCT ) examine two different type coronary artery stent use treat patient coronary artery disease .</brief_summary>
	<brief_title>Optical Coherence Tomography Assessment Intimal Tissue Malapposition</brief_title>
	<detailed_description>The development coronary stent significantly improve safety efficacy percutaneous coronary intervention ( PCI ) compare balloon angioplasty alone . Nevertheless , restenosis still encounter 20 40 % coronary lesion implantation bare metal stent , infer frequent repeat revascularization procedure negative impact quality life health care expenditures . Drug-eluting stent ( DES ) , control release therapeutic agent , significantly reduce rate major adverse cardiac event ( MACE ) follow coronary stent implantation , primarily reduction restenosis target lesion revascularization . Optical coherence tomography ( OCT ) optical analogue intravascular ultrasound ( IVUS ) : us infrared light source ( wavelength 1310nm ) measure backscatter light technique similar conventional ultrasound . With technique resolution 10μm in-vivo report , far good level resolution compare IVUS . Optical coherence tomography use vivo detect early atherosclerotic plaque previously visualise IVUS . Segments strut malapposition presence thickness neointimal hyperplasia also accurately assessed OCT compare IVUS . The present study utilize image capability OCT ass stent strut malapposition tissue coverage two different type DES . The biolimus-eluting stent eludes biolimus biodegradable polylactic acid polymer abluminal surface stainless steel stent . This stent compare randomized fashion permanent polymer base everolimus-eluting coronary stent make cobalt chromium alloy .</detailed_description>
	<mesh_term>Heart Diseases</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Everolimus</mesh_term>
	<mesh_term>Sirolimus</mesh_term>
	<criteria>Age ≥ 18 year Symptomatic coronary artery disease include patient chronic stable angina , silent ischemia , acute coronary syndrome include nonST elevation myocardial infarction Presence one coronary artery stenosis &gt; 50 % native coronary artery reference diameter range 2.25 4.0 mm cover one multiple stents No limitation number treat lesion , number vessel lesion length accord randomization group Known intolerance aspirin , clopidogrel , heparin , stainless steel , cobalt chromium , Biolimus , everolimus , contrast material Acute STsegment elevation myocardial infarction Bypass graft Inability provide inform consent Pregnancy Planned surgery within 12 month PCI unless dual antiplatelet therapy maintain throughout perisurgical period Left ventricular ejection fraction &lt; 25 % Serum creatinine &gt; 180mmol/L</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2014</verification_date>
	<keyword>Drug-eluting stent</keyword>
	<keyword>Tomography , Optical Coherence</keyword>
</DOC>